3 free views remaining today
oculocerebrorenal syndrome
ICD-10 Codes
Related ICD-10:
Description
Oculocerebrorenal Syndrome (Lowe Syndrome): A Rare Genetic Disorder
Oculocerebrorenal syndrome, also known as Lowe syndrome, is a rare X-linked recessive multisystem disorder that primarily affects males. The condition is characterized by a triad of congenital cataracts, intellectual disability, and renal tubular dysfunction with slowly progressive renal failure.
Key Features:
- Congenital Cataracts: Dense congenital cataracts are found in all affected boys, which can lead to impaired vision.
- Intellectual Disability: Affected individuals often experience developmental delay, seizures, and severely impaired intellectual development.
- Renal Tubular Dysfunction: The condition is associated with renal tubular dysfunction, leading to Fanconi syndrome (bicarbonaturia, renal tubular acidosis, potassium loss, and sodium loss).
- Other Symptoms: Additional symptoms may include hypotonia (reduced muscle tone), feeding difficulties, infantile glaucoma, strabismus, hypermetropia, corneal and conjunctival cheloids, and cystic lesions in the brain.
Prevalence and Genetics
Lowe syndrome is a rare condition, with an estimated prevalence of approximately 1 in 500,000. It is inherited in an X-linked recessive pattern, meaning that the gene responsible for the condition is located on the X chromosome. The condition primarily affects males, as they have only one X chromosome.
References
- GeneReviews: A detailed medical description of Lowe syndrome can be found on this website.
- Pediat. Nephrol.: The oculocerebrorenal syndrome of Lowe: an update (2016)
Additional Characteristics
- Feeding difficulties
- Hypermetropia
- Seizures
- Strabismus
- Intellectual disability
- Developmental delay
- Congenital cataracts
- Hypotonia (reduced muscle tone)
- Renal tubular dysfunction with slowly progressive renal failure
- Dense congenital cataracts
- Fanconi syndrome (bicarbonaturia, renal tubular acidosis, potassium loss, and sodium loss)
- Infantile glaucoma
- Corneal and conjunctival cheloids
- Cystic lesions in the brain
Signs and Symptoms
Signs and Symptoms of Oculocerebrorenal Syndrome (Lowe Syndrome)
Oculocerebrorenal syndrome, also known as Lowe syndrome, is a rare genetic disorder that affects the eyes, brain, and kidneys. The signs and symptoms of this condition can vary in severity and may be present from birth or develop over time.
Common Signs and Symptoms:
- Congenital Cataracts: Thick clouding of the lenses in both eyes, which can impair vision.
- Infantile Glaucoma: A rare eye disease that can cause increased pressure in the eyes, leading to vision loss.
- Hypotonia: Reduced muscle tone, which can lead to feeding difficulties and other developmental delays.
- Intellectual Disability: Affected individuals may experience intellectual disability, ranging from mild to severe.
- Renal Tubular Dysfunction: A condition that affects the kidneys' ability to filter waste and excess fluids.
Additional Signs and Symptoms:
- Seizures: Some individuals with Lowe syndrome may experience seizures.
- Postnatal Growth Retardation: Affected children may experience delayed growth and development.
- Vision Loss: Congenital cataracts and infantile glaucoma can lead to permanent vision loss.
Age-Related Manifestations:
The manifestation of different symptoms over time is summarized in Table 1 (see reference [11] for details).
These signs and symptoms are often present from birth, but some may develop later in life. It's essential to note that every individual with Lowe syndrome is unique, and the severity and progression of symptoms can vary greatly.
References:
[4], [5], [6], [7], [8], [9], [10], [11]
Additional Symptoms
- Hypotonia
- Seizures
- Intellectual Disability
- Renal Tubular Dysfunction
- Congenital Cataracts
- Infantile Glaucoma
- Postnatal Growth Retardation
- loss of vision
Diagnostic Tests
Diagnostic Tests for Oculocerebrorenal Syndrome (Lowe Syndrome)
Oculocerebrorenal syndrome, also known as Lowe syndrome, is a rare genetic disorder that affects the eyes, brain, and kidneys. Diagnosing this condition can be challenging, but several diagnostic tests are available to confirm the diagnosis.
- Genetic Testing: Genetic testing is considered the definitive test for diagnosing oculocerebrorenal syndrome. This involves analyzing the OCRL gene, which is responsible for the disease. The test can be performed on a blood sample or cultured skin fibroblasts [6][10].
- Enzyme Activity Test: An enzyme activity test measures the level of inositol polyphosphate-5-phosphatase activity in cultured skin fibroblasts. This test is considered more specific and sensitive than genetic testing [2][4].
- Biochemical Testing: Biochemical testing involves measuring the levels of reducing substances, low urine osmolality, elevated 24-hour volumes, proteinuria, and aminoaciduria in the urine [4].
- Molecular Genetic Testing: Molecular genetic testing can be used to confirm the diagnosis by detecting mutations in the OCRL gene. This test is particularly useful for prenatal diagnosis [8][12].
Prenatal Diagnosis
Prenatal diagnosis of oculocerebrorenal syndrome is available through biochemical testing or molecular genetic testing if the OCRL gene mutation has been determined in an affected family member [8]. This can provide valuable information to expectant parents and help them prepare for the birth of their child.
References:
[1] Lowe et al. (1952) - First described oculocerebrorenal syndrome [2] Suchy et al. (1998) - Reported prenatal diagnosis through biochemical testing [4] Context 2, 4, and 12 - Various diagnostic tests mentioned [6] Context 6 - Measurement of inositol polyphosphate-5-phosphatase enzyme activity in cultured skin fibroblasts [8] Context 8 - Prenatal diagnosis available through biochemical testing or molecular genetic testing [10] Context 10 and 13 - Genetic testing considered the definitive test for diagnosing oculocerebrorenal syndrome [12] Context 12 - Molecular genetic testing used to confirm the diagnosis by detecting mutations in the OCRL gene
Treatment
Treatment Options for Oculocerebrorenal Syndrome
Oculocerebrorenal syndrome, also known as Lowe syndrome, is a rare genetic disorder that affects the eyes, brain, and kidneys. While there is no cure for this condition, various treatments can help manage its symptoms.
- Behavioral Problems: Treatment includes behavior modification programs, individualized therapy, and medications such as clomipramine, paroxetine, and risperidone to address behavioral problems [3][5].
- Renal Tubular Acidosis: Oral supplements of sodium and potassium bicarbonate or citrate are used to correct acidosis and hypokalaemia [6][7]. Oral phosphate and oral calcitriol (1,25-dihydroxyvitamin D) may also be prescribed to manage electrolyte imbalances.
- Glaucoma Control: Medications are used to control glaucoma in affected individuals [8].
- Nutritional Support: Nasogastric tube feeding or other forms of nutritional support may be necessary to ensure adequate nutrition and hydration [9].
Other Treatments
- Cataract Extraction: Cataracts, a common feature of Lowe syndrome, can be surgically removed to improve vision.
- Physical Therapy: Physical therapy can help manage muscle weakness and hypotonia associated with the condition.
- Speech Therapy: Speech therapy may be necessary to address communication difficulties.
Important Note
Treatment for oculocerebrorenal syndrome is primarily symptomatic and supportive, focusing on managing specific symptoms rather than addressing the underlying genetic cause. A multidisciplinary approach involving various healthcare professionals is often necessary to provide comprehensive care.
References:
[3] The oculocerebrorenal syndrome of Lowe: an update. [5] Treatment also includes physical and speech therapy, use of drugs (clomipramine, paroxetine and risperidone) for behavioral problems, correction of tubular ... [6] Apr 24, 2018 — Sodium citrate and potassium bicarbonate or citrate are used to correct acidosis and hypokalaemia. [7] Oral phosphate and oral calcitriol (1,25-dihydroxyvitamin D) may also be prescribed to manage electrolyte imbalances. [8] Glaucoma control medications are used in affected individuals. [9] Most children have their cataracts removed during infancy.
Recommended Medications
- oral phosphate
- glaucoma control medications
- calcitriol
- Calcitriol
- clomipramine
- Clomipramine
- paroxetine
- Paroxetine
- risperidone
- Risperidone
- Sodium Bicarbonate
- sodium hydrogencarbonate
- potassium citrate
- potassium citrate monohydrate
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for oculocerebrorenal syndrome (Lowe syndrome) includes several conditions that can present with similar symptoms. Some of these conditions are:
- Dent disease type 2
- Nance-Horan syndrome
- Congenital infections, such as rubella
- Mitochondrial disorders, such as Leber congenital optic neuropathy
- Cystinosis
- Fanconi Syndrome
- Hypophosphatemic Rickets
These conditions can be ruled out through various diagnostic tests and evaluations. For example, a diagnosis of Lowe syndrome can be confirmed by genetic testing for mutations in the OCRL1 gene.
It's worth noting that the differential diagnoses listed above are based on information from search results [3][4][5][6][7]. A comprehensive evaluation by a medical professional is necessary to determine the correct diagnosis and develop an appropriate treatment plan.
Additional Differential Diagnoses
- Nance-Horan syndrome
- Hypophosphatemic Rickets
- Congenital infections (e.g., rubella)
- Mitochondrial disorders (e.g., Leber congenital optic neuropathy)
- Dent disease
- Fanconi syndrome
- cystinosis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_7169
- owl#annotatedSource
- t393424
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- OMIM mapping confirmed by DO. [SN].
- oboInOwl#id
- DOID:1056
- core#notation
- DOID:1056
- oboInOwl#hasDbXref
- UMLS_CUI:C0028860
- IAO_0000115
- A syndrome that has_material_basis_in mutation in the OCRL gene on chromosome Xq26 and that is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, amino aciduria, and reduced ammonia production by the kidney.
- oboInOwl#hasExactSynonym
- oculocerebrorenal syndrome of Lowe
- rdf-schema#label
- oculocerebrorenal syndrome
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- t393439
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000149
- relatedICD
- http://example.org/icd10/E72.03
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.